Lilly Collins

Lilly Collins has worked in the pharmaceutical industry since 2016. Lilly began their career as a Scientist in DMPK at Sygnature Discovery, where they were promoted to Senior Scientist 1 and then Senior Scientist 2 in DMPK. In 2019, they joined DMDG as a DMDG Apprentice Committee Member. In 2021, Lilly moved to Quotient Sciences as a Project Manager, and in 2022 they joined Eliem Therapeutics as a Project Manager Pre-Clinical & CMC.

Lilly Collins attended the University of Lincoln from 2012 to 2015, where they earned a Bachelor of Science in Forensic Science.